Updates are available New edition dated 2022-09-22

Click to view New edition: https://doi.org/10.17352/2640-7973.000020

Contrary to expectation: Preserved renal function after using PD-1 Inhibitor Cemiplimab-rwlc in a kidney transplant recipient

Crossref DOI link: https://doi.org/10.17352/2640-7973.000020

Published Online: 2022-09-22

Update policy: https://doi.org/10.17352/crossmark-policy

About CrossMark